Mercury Laboratories Ltd - 538964 - Audited Results For The Quarter And Year Ended On March 31, 2024
In earlier attached financial statement missed to attached auditors report inadvertently. There is no any other change28-05-2024
28-05-2024
Mercury Laboratories Ltd - 538964 - Intimation For Appointment Of Secretarial, Internal And Cost Auditor For The FY 2024-25 Announcement Under Reg 30 Of SEBI(LODR)
Intimation for appointment of secretarial, internal and cost auditors for the FY 2024-25 is attached28-05-2024
Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend Updates is attched28-05-2024
Mercury Laboratories Ltd - 538964 - Audited Results For The Quarter And Year Ended On March 31, 2024
Audited Financial results for the quarter and year ended on March 31, 2024 is attached28-05-2024
Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outcome Of The Board Meeting - May 28, 2024
Outcome of Board Meeting held on May 28, 2024 is attached28-05-2024
Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of advertisement published in newspapers regarding Notice of transfer of equity shares to IEPF23-05-2024
Mercury Laboratories Ltd - 538964 - Intimation To Shareholders Relating To Transfer Of Equity Shares To The Investor Education And Protection Fund (IEPF) Authority
A copy of intimation to shareholders relating to transfer of Equity Shares to the Investor Education and Protection Fund (IEPF) Authority22-05-2024
Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended On March 31, 2024
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended on March 31, 2024 together with the Directors' Report together with the Directors' Report. 2.To recommend final dividend for the year ended on March 31, 2024, if any, subject to approval of shareholders at the ensuing Annual General Meeting. 3.Appointment of Secretarial Auditor for the Financial Year 2024-25 4.Appointment of Internal Auditor for the FY 2024-25 5.Appointment of Cost Auditor for the FY 2024-25 6.any other items of Agenda, if any21-05-2024
Mercury Laboratories Ltd - 538964 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate Share certificate intimation_Pankaj Ved20-05-2024
Mercury Laboratories Ltd - 538964 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for Loss of Share Certificate_Manish N Shah30-04-2024